- Home
- AGMB vs GOOD Comparison
AGMB vs GOOD Comparison
Compare AGMB & GOOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AGMB | GOOD |
|---|---|---|
| Founded | 2017 | 2003 |
| Country | Belgium | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 652.5M | 624.9M |
| IPO Year | 2024 | 2003 |
Fundamental Metrics
Financial Performance| Metric | AGMB | GOOD |
|---|---|---|
| Price | $13.90 | $12.79 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 1 |
| Target Price | ★ $32.00 | $12.50 |
| AVG Volume (30 Days) | 151.8K | ★ 327.4K |
| Earning Date | 04-23-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 9.54% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.18 |
| Revenue | N/A | ★ $161,336,000.00 |
| Revenue This Year | N/A | $9.89 |
| Revenue Next Year | $17.86 | $2.57 |
| P/E Ratio | ★ N/A | $71.44 |
| Revenue Growth | N/A | ★ 8.00 |
| 52 Week Low | $8.75 | $10.33 |
| 52 Week High | $17.82 | $13.28 |
Technical Indicators
Market Signals| Indicator | AGMB | GOOD |
|---|---|---|
| Relative Strength Index (RSI) | 50.47 | 44.30 |
| Support Level | $13.90 | $12.23 |
| Resistance Level | $14.94 | $12.92 |
| Average True Range (ATR) | 1.22 | 0.19 |
| MACD | 0.06 | -0.03 |
| Stochastic Oscillator | 34.28 | 6.43 |
Price Performance
Historical ComparisonAbout AGMB AgomAb Therapeutics NV American Depositary Shares
AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities, with a focus on addressing limitations associated with prior treatment approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.
About GOOD Gladstone Commercial Corporation Real Estate Investment Trust
Gladstone Commercial Corp is a real estate investment trust, which engages in investing and owning net leased industrial, commercial, and retail real property and making long-term industrial and commercial mortgage loans. Its portfolio consists of single-tenant commercial, industrial real properties, and medical properties nationwide. Its principal investment objectives are to generate income from rental properties.